Nina Horowitz
Company: ImmuneBridge
Job title: Chief Executive Officer
Seminars:
Chair’s Opening Remarks 8:50 am
day: Conference Day Two
Roundtable Discussion: Enhancing Allogeneic Cell Therapy Success by Optimizing Donor Selection Early in Development 10:00 am
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day One
Maximizing Process Yield Through Understanding Donor Variability 11:45 am
day: Conference Day One